Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aytu Biopharma (AYTU) Liabilities from Discontinued Operations: 2024

Historic Liabilities from Discontinued Operations for Aytu Biopharma (AYTU) over the last 1 years, with Jun 2024 value amounting to $557,000.

  • Aytu Biopharma's Liabilities from Discontinued Operations was N/A to $557,000 in Q2 2024 from the same period last year, while for Jun 2024 it was $557,000, marking a year-over-year change of. This contributed to the annual value of $557,000 for FY2024, which is N/A change from last year.
  • As of FY2024, Aytu Biopharma's Liabilities from Discontinued Operations stood at $557,000.
  • Aytu Biopharma's Liabilities from Discontinued Operations' 5-year high stood at $557,000 during FY2024, with a 5-year trough of $557,000 in FY2024.
  • In the last 1 years, Aytu Biopharma's Liabilities from Discontinued Operations had a median value of $557,000 in 2024 and averaged $557,000.